Administration and dosage Mode of Administration: Subcutaneous injection to a fleshy part of the body, typically to the stomach or abdominal area
Possible monitoring points include injection site irritation, flushing, headache, water retention, fatigue, appetite changes, or hormone-related effects
Same goes for MOTS-C, which is currently in an ongoing Phase 2a clinical trial evaluating its effects on insulin sensitivity in adults with prediabetes and obesity
Stable Gastric Pentadecapeptide BPC 157-NO-System Relation
Glutathione, known as the "King of Antioxidants," prevents cellular damage from free radicals and regenerates other antioxidants, making it crucial for the body's defense system
This applies especially when using it for injections or medication preparation